AVAILABLENot Applicable

A Compassionate Use (CU) Program of Odronextamab

Plain-language summary

Provide compassionate use of odronextamab

NCT IDNCT05619367

SponsorRegeneron Pharmaceuticals

Sponsor typeINDUSTRY

Study typeEXPANDED_ACCESS

Requests for compassionate use must be initiated by a treating physician Physicians should contact